First human test for new stroke treatment
NCT ID NCT04677777
Summary
This study tested the safety of an experimental drug called PP-007 in people who had just suffered a stroke caused by a blood clot. The 24 participants received two doses of the drug in addition to their standard stroke treatments, like clot-busting medication or removal. Researchers primarily checked for side effects, while also looking at early signs of whether the drug might help improve blood flow and reduce brain damage.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baptist Health Miami Cardiac & Vascular Institute (MCVI)
Miami, Florida, 33176, United States
-
Baptist Health Research Institute
Jacksonville, Florida, 32207, United States
-
Emory University School of Medicine
Atlanta, Georgia, 30303, United States
-
Mercy Health - St. Vincent Medical Center
Toledo, Ohio, 43608, United States
-
Oregon Stroke Center at Oregon Health & Science University (OHSU)
Portland, Oregon, 97239, United States
-
Saint Luke's Hospital
Kansas City, Missouri, 64111, United States
-
UPMC Stroke Institute
Pittsburgh, Pennsylvania, 15213, United States
-
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, 73104, United States
Conditions
Explore the condition pages connected to this study.